September 30, 2016 11:10 AM ET


Company Overview of Claris Lifesciences Limited

Company Overview

Claris Lifesciences Limited, together with its subsidiaries, manufactures and sells drugs and pharmaceuticals worldwide. It manufactures and markets products for anesthesia and analgesics, blood products, anti-infectives, plasma volume expanders, critical care, and nephrology areas, as well as for infusion therapy and nutrition applications. The company also provides dialysis and transplant range across systems, solutions, medicines, disposables, and equipment. In addition, it offers injectables for various therapeutic groups, including anti-emetics, CNS, cardiology, anti-malaria, haematinics, etc. The company offers its products through various delivery systems, such as glass and plastic bo...

Near Parimal Railway Crossing


Ahmedabad,  380006


Founded in 1994

1,324 Employees


91 79 2656 3331


91 79 2640 8053

Key Executives for Claris Lifesciences Limited

Vice Chairman, Managing Director, Member of Share Transfer Committee, Member of Executive Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders Relationship Committee
Age: 36
Total Annual Compensation: 6.0M
Chief Financial Officer, Whole Time Director, Member of Share Transfer Committee, Member of Executive Committee, Member of Audit Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders Relationship Committee
Age: 42
Total Annual Compensation: 9.7M
Senior Vice President, Compliance Officer and Company Secretary
Total Annual Compensation: 8.5M
Compensation as of Fiscal Year 2016.

Claris Lifesciences Limited Key Developments

Top PE Firms Reportedly Join Race For Claris Lifesciences’ US Business

Warburg Pincus LLC, Apax Partners LLP and The Blackstone Group L.P. (NYSE:BX) are in the race to acquire the US business of Claris Lifesciences Limited (BSE:533288). The business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma companies, people familiar with the development told Economic Times. A Claris spokesperson told ET that the company does not comment on market speculation. “The company continues to evaluate various growth options from time to time and we will continue to update the stock exchanges if there is any definitive development, as required by regulations."

Claris Lifesciences Receives New Drug Application Approval for Flumazenil Injection USP

Claris Lifesciences has received an Abbreviated New Drug Application (ANDA) approval for Flumazenil Injection USP, 0.5mg/mL and 1mg/10mL multiple dose vials, in the United States of America. The ANDA approval has come for the same plant where the FDA had recently completed their Prior Approval Inspection (PAI). The estimated market size in the US is $4 million. With this approval, the company now has a total of 16 approvals and 23 under approval ANDAs, the total addressable market size of the approved ANDAs is estimated to be a little above $300 million.

Carlyle Group Reportedly Prepares Bid For Claris Lifesciences's Injectable Drugs Business

The Carlyle Group LP (NasdaqGS:CG) to bid for injectable drugs business of Claris Lifesciences Limited (BSE:533288). Carlyle Group to partner with a drug maker to acquire Claris's business that is valued at $400-450 million. Claris has hired Jefferies LLC and Credit Suisse Group AG (SWX:CSGN) to find a buyer for the business.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Claris Lifesciences Limited, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at